NEEDLE, HYPODERMIC

The contract is for the procurement of hypodermic needles, gauge 21, with a unit of issue being a box of 12 each, delivered under solicitation SPE2DS-26-T-099V. The item is regulated by the FDA and must comply with stringent medical packaging and labeling standards, specifically Medical Marking Standard No. 1, which supersedes MIL-STD-129 for this acquisition. Each needle must be sealed in a protective unit container and packed in commercial shipping containers suitable for safe transport at the lowest cost to the destination, with palletization in accordance with DLA’s RP001 requirements. The shelf life is non-extendable at 60 months, and no more than nine months may have elapsed from the date of manufacture to the date of delivery to the government. All packaging must be marked with the NSN, manufacturer name and CAGE code, date of manufacture prefixed with "MFD", expiration or retest date, and contract or lot number. The delivery point is FPO AA 34089, designated as FOB destination, requiring delivery within 20 days of award, with a required delivery date of May 29, 2026. The contractor must use traceable means and is prohibited from using parcel post. The contract includes mandatory compliance with a comprehensive set of FAR and DFARS clauses addressing cybersecurity, equal opportunity, trafficking in persons, employment eligibility, hazardous materials, and safeguarding of defense information. Invoicing must be processed through WAWF, and the item must meet all technical and quality requirements outlined in the DLA Master List, which takes precedence over ASTM D3951. Pricing information is not specified in the contract, though historical unit costs range between $13.24 and $15.50. The procurement is for a single line item under a simplified acquisition process with no options, and the award will be made based on compliance with all technical, packaging, and regulatory requirements.